The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
The SCOUT-HCM trial hit its primary endpoint, showing a clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
The timing of the partnership is crucial, as Kerala’s fertility rate has dropped to approximately 1.35–1.7 children per woman, below the replacement level of 2.1
Call it a major breakthrough for diagnostic imaging
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
Subscribe To Our Newsletter & Stay Updated
